⚡️💥🇺🇸#VXRT
Vaxart: FDA Clears IND Application for S-Only Oral Tablet COVID-19 Vaccine Candidate
Vaxart: FDA Clears IND Application for S-Only Oral Tablet COVID-19 Vaccine Candidate
💥🇺🇸#VXRT
Vaxart отчитался о хорошем испытании своей антиковидной пилюли
Vaxart Announces Positive Top-line Phase II Clinical Study Data Demonstrating Safety and Immunogenicity of Its Wuhan S-Only COVID-19 Pill Vaccine Candidate
Vaxart отчитался о хорошем испытании своей антиковидной пилюли
Vaxart Announces Positive Top-line Phase II Clinical Study Data Demonstrating Safety and Immunogenicity of Its Wuhan S-Only COVID-19 Pill Vaccine Candidate